See All Slides - tctmd.com

Slides

Presentation THT 2024

DoReMe: Are Inotropes Helpful or Harmful?

Presenter: Benjamin Hibbert

March 05, 2024

Presentation THT 2024

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Presenter: Stavros G. Drakos

March 05, 2024

Presentation THT 2024

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Presenter: Kevin Makati

March 05, 2024

Presentation THT Abstracts 2024

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Presenter: Antoon van den Enden

March 05, 2024

Presentation THT Abstracts 2024

Beyond Supine Pulmonary Artery Pressures

Presenter: Marat Fudim

March 05, 2024

Presentation THT Abstracts 2024

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Presenter: Julia Baranowska

March 05, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Presenter: Matteo Fabbri

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Advertisement

Slides

DoReMe: Are Inotropes Helpful or Harmful?

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Beyond Supine Pulmonary Artery Pressures

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content